Salarius Pharmaceuticals, Inc.
SLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,779 | $17,061 | $26,134 | $20,521 |
| - Cash | $2,435 | $5,900 | $12,106 | $29,214 |
| + Debt | $222 | $290 | $0 | $0 |
| Enterprise Value | -$433 | $11,451 | $14,028 | -$8,694 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5,730 | -$12,885 | -$22,969 | -$12,794 |
| % Margin | – | – | – | – |
| Net Income | -$5,576 | -$12,543 | -$31,608 | -$12,768 |
| % Margin | – | – | – | – |
| EPS Diluted | -86.85 | -0.057 | -221.55 | -930 |
| % Growth | -152,268.4% | 100% | 76.2% | – |
| Operating Cash Flow | -$4,525 | -$12,846 | -$17,595 | -$10,200 |
| Capital Expenditures | $0 | -$0 | -$1,500 | $0 |
| Free Cash Flow | -$4,525 | -$12,846 | -$19,095 | -$10,200 |